Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e78393
Publisher
Public Library of Science (PLoS)
Online
2013-11-12
DOI
10.1371/journal.pone.0078393
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biomarker robustness reveals the PDGF network as driving disease outcome in ovarian cancer patients in multiple studies
- (2012) Rotem Ben-Hamo et al. BMC Systems Biology
- Performance of a multianalyte test as an aid for the diagnosis of ovarian cancer in symptomatic women
- (2012) Dominic J Autelitano et al. Journal of Translational Medicine
- Changes in pre-diagnostic serum C-reactive protein concentrations and ovarian cancer risk: a longitudinal study
- (2011) A. T. Toriola et al. ANNALS OF ONCOLOGY
- Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
- (2011) Nuh N Rahbari et al. BMC CANCER
- Recent progress in the diagnosis and treatment of ovarian cancer
- (2011) Danijela Jelovac et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
- (2011) C. S. Zhu et al. Cancer Prevention Research
- Comparison of candidate serologic markers for type I and type II ovarian cancer
- (2011) Dan Lu et al. GYNECOLOGIC ONCOLOGY
- A novel proteomic biomarker panel as a diagnostic tool for patients with ovarian cancer
- (2011) Claus Høgdall et al. GYNECOLOGIC ONCOLOGY
- Overview of anti-angiogenic agents in development for ovarian cancer
- (2011) Robert A. Burger GYNECOLOGIC ONCOLOGY
- Proteomic biomarkers apolipoprotein A1, truncated transthyretin and connective tissue activating protein III enhance the sensitivity of CA125 for detecting early stage epithelial ovarian cancer
- (2011) Charlotte H. Clarke et al. GYNECOLOGIC ONCOLOGY
- Possible Use of CA-125 Level Normalization After the Third Chemotherapy Cycle in Deciding on Chemotherapy Regimen in Patients With Epithelial Ovarian Cancer
- (2011) Malgorzata E. Skaznik-Wikiel et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic Impact of Prechemotherapy Serum Levels of HER2, CA125, and HE4 in Ovarian Cancer Patients
- (2011) Karina Dahl Steffensen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Prognostic and predictive relevance of CA-125 at primary surgery of ovarian cancer
- (2011) Dina Mury et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Early Decline in Cancer Antigen 125 as a Surrogate for Progression-Free Survival in Recurrent Ovarian Cancer
- (2011) Chee K. Lee et al. JNCI-Journal of the National Cancer Institute
- Comprehensive Serum Profiling for the Discovery of Epithelial Ovarian Cancer Biomarkers
- (2011) Ping Yip et al. PLoS One
- Immunity, Inflammation, and Cancer
- (2010) Sergei I. Grivennikov et al. CELL
- Inflammation: A driving force speeds cancer metastasis
- (2010) Yadi Wu et al. CELL CYCLE
- Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass
- (2010) Brian Nolen et al. GYNECOLOGIC ONCOLOGY
- CA125 nadir concentration is an independent predictor of tumor recurrence in patients with ovarian cancer: A population-based study
- (2010) Anne M. van Altena et al. GYNECOLOGIC ONCOLOGY
- Phase II biomarker trial of a multimarker diagnostic for ovarian cancer
- (2010) Tracey Edgell et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- Development of a Multimarker Assay for Early Detection of Ovarian Cancer
- (2010) Zoya Yurkovetsky et al. JOURNAL OF CLINICAL ONCOLOGY
- C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy)
- (2009) Eva Lundin et al. CANCER CAUSES & CONTROL
- Development and Validation of a Protein-based Signature for the Detection of Ovarian Cancer
- (2009) Kyongjin Kim et al. CLINICS IN LABORATORY MEDICINE
- Serum C-reactive protein in the differential diagnosis of ovarian masses
- (2009) Katrin Hefler-Frischmuth et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Development and Preliminary Evaluation of a Multivariate Index Assay for Ovarian Cancer
- (2009) Suraj D. Amonkar et al. PLoS One
- Early detection of ovarian cancer
- (2008) Partha M Das et al. Biomarkers in Medicine
- Diagnostic Markers for Early Detection of Ovarian Cancer
- (2008) I. Visintin et al. CLINICAL CANCER RESEARCH
- Evaluation of biomarker panels for early stage ovarian cancer detection and monitoring for disease recurrence
- (2008) Laura J. Havrilesky et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started